CoChat

Modulation of several waves of gene expression during FGF‐1 induced epithelial‐mesenchymal transition of carcinoma cells

Billottet, Clotilde, Tuefferd, Marianne, Gentien, David, Rapinat, Audrey, Thiery, Jean‐Paul, Broët, Philippe, Jouanneau, Jacqueline · 2008 · Journal of Cellular Biochemistry
Cited by 64

The DOI matches its Crossref record; 4 of the 4 references it cites were found in a registry or an index.

Abstract

During epithelial‐mesenchymal transition (EMT), epithelial cells are converted into isolated motile and invasive mesenchymal cells. In model systems, EMT is induced most often by the activation of tyrosine kinase receptors through signaling pathways involving translational and post‐translational regulation. In this study, we have used the NBT‐II bladder carcinoma cell system to investigate in vitro Fibroblast Growth Factor‐1 (FGF‐1)‐induced EMT. Transcriptome analyses were performed on NBT‐II cells stimulated for 2, 6, 24, and 48 h with FGF‐1. As some phenotypic changes occurred around 6 h post‐stimulation, a supervised analysis was designed to identify transcript variations across defined time‐periods. Our results clearly indicate that immediately after FGF‐1 stimulation a set of genes assigned to transcriptional regulation (e.g., jun‐B and v‐ets) and to EMT induction (e.g., Notch 1) is transiently up‐regulated. A set of genes involved in proteolytic systems (e.g., MMP‐13 and uPAR) is immediately up‐regulated but subsequently maintained throughout FGF‐1 stimulation. Then follows a second wave of gene expression that includes a strong but transient up‐regulation of ephrin B1 and arginase I. Finally, a third group of genes is stably modulated over 48 h which consists primarily of down‐regulated genes specifically associated with the EMT‐based loss of the epithelial phenotype and maintenance of the mesenchymal and invasive phenotype of carcinoma cells. Using genome‐wide oligoarray technology, we have identified novel expressions of immediate, immediate‐early and later EMT biomarkers that are specifically activated downstream of the FGF/FGFR pathway and which might be significant prognostic factors for tumor progression of carcinoma. J. Cell. Biochem. 104: 826–839, 2008. © 2008 Wiley‐Liss, Inc.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1002/jcb.21667

Cites

4 of 4 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 4 references

Cited by

Metadata

Authors
Billottet, C., Tuefferd, M., Gentien, D., Rapinat, A., Thiery, J., Broët, P., & Jouanneau, J.
Venue
Journal of Cellular Biochemistry
Publisher
Wiley
Published
2008-01-11
Volume
104
Issue
3
Pages
826-839
ISSN
  • 0730-2312 (ISSN-L)
  • 1097-4644
OpenAlex
W1991031388
Cited by
64
References
4
FWCI
2.31
Type
journal article
Language
en
Open access
closed

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.